thumbnail image
broken image
broken image

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LeukoPrint
    • PanCanSeek
    • LungCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
      • PanCanSeek
      • LungCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry
broken image
broken image

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LeukoPrint
    • PanCanSeek
    • LungCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
      • PanCanSeek
      • LungCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry
broken image
  • LungCanSeekTM

    Blood-based lung cancer early detection service

    Lung cancer is the most common type of cancer worldwide, with the highest incidence and mortality rates. The 5-year survival rate for advanced lung cancer is less than 20%, while the survival rate for early-stage lung cancer is over 60%. Early screening for lung cancer is key to extending patient survival and lowering mortality rates.

    LungCanSeekTM is an artificial intelligence (AI) algorithm-based early lung cancer screening service designed to identify cancer at its curable stage, enabling timely intervention to improve clinical outcomes.

    Lung cancer

    Non-invasive

    Early detection

    Cost-effective

  • Highlights

    • LungCanSeekTM is a blood-based non-invasive and cost-effective test for lung cancer early detection.
    • Early lung cancer detection was achieved by calculating the probability of lung cancer (POLC) index based on the concentration of four lung cancer related protein tumor markers (PTMs).
    • When cancer signals are detected, the subtype of lung cancer is predicted.

    broken image

    LungCanSeekTM offering 83.5% sensitivity, 90.3% specificity, and 77.4% subtype classification accuracy. Its can be utilized for the initial screening, followed by low-dose computed tomography (LDCT) for the individuals who tested positive in the initial screening. This two-step approach capitalizes on LungCanSeekTM's ease to perform, low cost, and high specificity to mitigate LDCT's false positive issue.

  • Indicated subjects

    broken image

    Adults aged 50+

    Family history of lung cancer

    At least a 20-pack year smoking history

    History of emphysema/COPD

    Long-term exposure to cancer-causing environments

    Unhealthy lifestyle

  • Specifications

    ◉ Sample requirement:4ml peripheral blood

    ◉ Result readout:Probability of lung cancer (POLC)

    ◉ Turnaround time (TAT):5 working days

  •  

    How it works

    broken image

    Customer order

    Customers can place orders through SeekIn official website or local agents

    broken image

    Blood-draw

    4ml venous peripheral blood collected in cell-free DNA BCT and can be stably stored at room temperature for 7 days

    broken image

    Testing

    Detection by Roche cobas e411 instrument

    broken image

    Reporting

    The test results will be ready in about 5 workdays after your blood draw arrived at central lab

  • Please review the instructions to gain a better understanding of LungCanSeekTM and assess whether it meets your needs.

    Download the Instructions

Navigation

Technology   

SeekInCare

SeeInCure

SeekInClarity

OncoSeek

Research

Contact Us

10320 Camino Santa Fe, Suite G

San Diego, CA 92121

United States

info@seekincancer.com

© 2024 SeekIn Inc.

All Rights Reserved.

Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More